![Le Monde](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/058/normal/le_monde.png?1369846943)
![Le Monde](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/058/normal/le_monde.png?1369846943)
Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors
AP News,
Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…
![ProfitQuotes.com](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/276/normal/logo7E.jpg?1567155044)
Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors
ProfitQuotes.com,
Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…
![PR Newswire](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/545/normal/Screen_Shot_2016-01-06_at_16.29.18.png?1452097789)
Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors
PR Newswire,
Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…